Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease-Reference-Cited by-同舟云学术

Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease

Published:2019-03-01 Issue:3 Volume:179 Page:446
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Morden Nancy E.¹,Woloshin Steven¹,Brooks Corinne G.¹,Schwartz Lisa M.¹

Affiliation:

1. The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

http:///jamainternalmedicine/article-pdf/179/3/446/17346388/jamainternal_morden_2018_ld_180061.pdf

Reference6 articles.

1. Adverse events associated with testosterone administration.;Basaria;N Engl J Med,2010

2. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.;Finkle;PLoS One,2014

3. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.;Vigen;JAMA,2013

4. US Food and Drug Administration. FDA evaluating risk of stroke, heart attack and death with FDA-approved testosterone products. FDA Drug Safety Communication. https://www.fda.gov/downloads/Drugs/DrugSafety/UCM383909.pdf. Published January 31, 2014. Accessed March 5, 2018.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone replacement in men with sexual dysfunction;Cochrane Database of Systematic Reviews;2024-01-15

2. Exogenous Testosterone Replacement Therapy Is Associated with Increased Risk for Vascular Graft Infections Among Hypogonadal Men;Annals of Vascular Surgery;2023-11

3. Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014;The Joint Commission Journal on Quality and Patient Safety;2023-09

4. Testosterone Prescribing in Texas, 2018–2021;Journal of General Internal Medicine;2023-07-12

5. Hormones and Aging: An Endocrine Society Scientific Statement;The Journal of Clinical Endocrinology & Metabolism;2023-06-16